Literature DB >> 16350444

Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.

Fangru Lian1, Clay J Cockerell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16350444     DOI: 10.1016/j.yadr.2005.06.005

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


× No keyword cloud information.
  6 in total

1.  Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.

Authors:  Jun Zhang; Brigid Stirling; Stephane T Temmerman; Chi A Ma; Ivan J Fuss; Jonathan M J Derry; Ashish Jain
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

Review 2.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  A rare case of multiple segmental eccrine spiradenomas.

Authors:  Laura Englander; Jason J Emer; Danielle McClain; Bijal Amin; Ryan B Turner
Journal:  J Clin Aesthet Dermatol       Date:  2011-04

Review 4.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

5.  Differential diagnosis of eccrine spiradenoma: A case report.

Authors:  Yan Zheng; Qiong Tian; Juan Wang; Xinyu Dong; Huiling Jing; Xin Wang; Yiguo Feng; Shengxiang Xiao
Journal:  Exp Ther Med       Date:  2014-08-14       Impact factor: 2.447

6.  A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family.

Authors:  Ruizheng Zhu; Jie Xu; Juan Shen; Wenru Li; Fei Tan; Changchang Li; Zhichen Wei; Yeqiang Liu; Yun Bai
Journal:  Mol Genet Genomic Med       Date:  2020-08-11       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.